摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-ethyl-N-(2-iodobenzyl)ethanamine | 99558-03-9

中文名称
——
中文别名
——
英文名称
N-ethyl-N-(2-iodobenzyl)ethanamine
英文别名
1-(2-iodobenzyl)-1,1-diethylamine;N,N-diethyl-2-iodobenzylamine;NN-diethyl-o-iodobenzylamine;ortho-C6H4I(CH2N(C2H5)2);Diethyl[(2-iodophenyl)methyl]amine;N-ethyl-N-[(2-iodophenyl)methyl]ethanamine
N-ethyl-N-(2-iodobenzyl)ethanamine化学式
CAS
99558-03-9
化学式
C11H16IN
mdl
MFCD06797847
分子量
289.159
InChiKey
XQFQHCGPQLYBOG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    3.2
  • 氢给体数:
    0
  • 氢受体数:
    1

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Kinetics of the Oxidative Addition ofortho-Substituted Aryl Halides to Palladium(0) Complexes
    作者:Mouad Alami、Christian Amatore、Samia Bensalem、Abdelharim Choukchou-Brahim、Anny Jutand
    DOI:10.1002/1099-0682(200109)2001:10<2675::aid-ejic2675>3.0.co;2-j
    日期:2001.9
    participate in the oxidative addition by a preliminary complexation of the active Pd0(PPh3)2 or Pd0(dppp) complex. The observed decelerating effect induced by the ortho substituents is due to steric hindrance and electronic donor effects and is less important for aryl bromides than for aryl iodides; ortho-substituted aryl iodides remain more reactive than ortho-substituted aryl bromides for both ligands
    邻位取代芳基卤化物氧化加成的速率常数,o-ZCH2-C6H4-X [X = I, Br; Z = OMe, NEt2, N(CH2)5] 到 Pd0(PPh3)4 或 Pd0(dba)(dppp) 从 Pd0(dba)2 和 1 equiv 生成。dppp 的确定。邻位取代的芳基卤化物的氧化加成比相应的未取代或间位取代的芳基卤化物的氧化加成慢。此处研究的邻位取代基不通过活性 Pd0(PPh3)2 或 Pd0(dppp) 复合物的初步络合参与氧化加成。观察到的由邻位取代基引起的减速效应是由于空间位阻和电子供体效应,对于芳基溴化物不如芳基碘化物重要;对于配体 PPh3 和 dppp,邻位取代芳基碘化物比邻位取代芳基溴化物更具反应性。
  • Radioiodinated analogs of xylamine: N-(2-chloroethyl)-N-ethyl-2-[125I]iodobenzylamine and N,N-diethyl-2-[125I]iodobenzylamine as potential tools for monoamine uptake exploration by spect
    作者:C. Branger、L. Garreau、Y. Frangin、S. Chalon、P. Dubois、A.-M. Dognon、J.-E. Ombetta-Goka、J.-C. Besnard、D. Guilloteau
    DOI:10.1002/jlcr.2580360711
    日期:1995.7
    In order to improve the scintigraphy and radiotherapy of neuroendocrine tumors we synthesized two radioiodinated benzylamines [N-(2-chloroethyl)-N-ethyl-2-[125I]iodobenzylamine and N,N-diethyl-2-[125I]iodobenzylamine], analogs of xylamine [N-(2-chloroethyl)-N-ethyl-2-methylbenzylamine]. Xylamine is an irreversible inhibitor of uptake and accumulation of noradrenaline. The two unlabelled iodinated derivatives [N-(2-chloroethyl)-N-ethyl-2-iodobenzylamine and N,N-diethyl-2-iodobenzylamine] were synthesized, purified and checked by HPLC, NMR and mass spectrography. Their affinity for the noradrenaline transporter was determined in vitro on rat brain membrane homogenates with [3H]nisoxetine. Radioiodination was performed by iodide for bromide nucleophilic exchange from brominated precursors. The N,N-diethyl-2-[125I]iodobenzylamine was obtained directly from N,N-diethyl-2-bromobenzylamine. Radiosynthesis of N-(2-chloroethyl)-N-ethyl-2-[125I]iodobenzylamine required three steps. A new brominated precursor [N-ethyl-N-(2-bromobenzyl)glycine ethyl ester] which was stable for radiolabelling and suitable for reduction to N-(2-hydroxyethyl)-N-cthyl-2-[125I]iodobenzylamine was synthesized. N-(2-Hydroxyethyl)-N-ethyl-2-[125I]iodobenzylamine was converted to N-(2-chloroethyl)-N-ethyl-2-[125I]iodobenzylamine in the presence of an excess of thionyl chloride. Radioiodinated derivatives were purified and checked by HPLC.
    为了改进神经内分泌肿瘤的闪烁成像和放射治疗,我们合成了两种放射性碘化苄胺[N-(2-氯乙基)-N-乙基-2-[125I]碘苄胺和 N,N-二乙基-2-[125I]碘苄胺],它们是二甲胺[N-(2-氯乙基)-N-乙基-2-甲基苄胺]的类似物。二甲胺是去甲肾上腺素摄取和蓄积的不可逆抑制剂。我们合成并纯化了两种未标记的碘化衍生物[N-(2-氯乙基)-N-乙基-2-碘苄胺和 N,N-二乙基-2-碘苄胺],并通过高效液相色谱法、核磁共振法和质谱法对其进行了检测。体外用[3H]尼索西汀测定了它们对大鼠脑膜匀浆中去甲肾上腺素转运体的亲和力。放射性碘化是通过碘化物与溴化前体的亲核交换进行的。N,N-二乙基-2-[125I]碘苄胺是直接从 N,N-二乙基-2-溴苄胺中获得的。N-(2-氯乙基)-N-乙基-2-[125I]碘苄胺的放射合成需要三个步骤。我们合成了一种新的溴化前体[N-乙基-N-(2-溴苄基)甘氨酸乙酯],它对放射性标记稳定,适合还原成 N-(2-羟乙基)-N-辛基-2-[125I]碘苄胺。在过量亚硫酰氯的存在下,N-(2-羟乙基)-N-乙基-2-[125I]碘苄胺转化为 N-(2-氯乙基)-N-乙基-2-[125I]碘苄胺。放射性碘化衍生物经高效液相色谱法纯化和检测。
  • α-Alkylation of amines via a 1,5-hydrogen shift
    作者:Kjell Undheim、Lorenzo Williams
    DOI:10.1039/c39940000883
    日期:——
    Radicals derived from N-(2-iodobenzyl)‘protected’ amines undergo a 1,5-hydrogen shift to give more stable α-amino radicals, which can be subsequently trapped by electron deficient alkenes.
    衍生自N-(2-碘苄基)'保护的'胺的自由基进行1,5-氢转移,得到更稳定的α-氨基,这些自由基随后可被缺乏电子的烯烃捕获。
  • Yoshikai, Naohiko; Mieczkowski, Adam; Matsumoto, Arimasa, Journal of the American Chemical Society, 2010, vol. 132, p. 5568 - 5569
    作者:Yoshikai, Naohiko、Mieczkowski, Adam、Matsumoto, Arimasa、Ilies, Laurean、Nakamura, Eiichi
    DOI:——
    日期:——
  • Generation and alkylation of carbanions .alpha. to the nitrogen of amines by a new metallation procedure
    作者:Masahiro Murakami、Minoru Hayashi、Yoshihiko Ito
    DOI:10.1021/jo00029a001
    日期:1992.1
    Treatment of a tertiary amine having a pendent o-iodobenzyl group on nitrogen with SmI2 generates alpha-amino organosamarium, which reacts with electrophiles giving the corresponding C-C bound formation products in good yield.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐